top of page

Pro PG receives S19 A for Imipramine 25mg Tablets

Apr 13, 2022
1 min read

Updated: Aug 28

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position.

For current Australian shortage and supply information, see medicine shortages in Australia.



​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 25mg Tablets until 30th September 2022.


Import and supply approved until: 30th Sept 2022

Imipramine 25mg tablets are currently experiencing a shortage of supply in Australia with Tofranil 25mg not available.

Product: IMIPRAMINE HYDROCHLORIDE TABLETS USP, 25 MG 100 TABLETS (LEADING PHARMA LLC) S19a​

Stock availability: On hand

Ordering

Orders can be placed directly via our website www.propg.com.au , email: orders@propg.com.au or phone: 1300 077 674

Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Social Icon
  • Google+ Basic Square

Legal & Trademark Notice
© 2026 Pro Pharmaceuticals Group Pty Ltd. All rights reserved.
Pro PG, CheckMed, and their respective logos are registered trademarks owned worldwide by Pro Pharmaceuticals Group Pty Ltd.
Pro Pharmaceuticals Group operates globally through associated entities, including CTS Pharmaceuticals Pty Ltd (Australia), Jemstar Sp. z o.o. (Poland), and Pro Pharmaceuticals Group NZ Ltd (New Zealand).

International Tax Registrations:
ABN 20 605 457 430 (Australia) | VAT DE401757398 (EU VAT ID) | Steuernummer 15/460/00493 (Germany) | VAT PL5263362401 (Poland) | VAT NL825524295B01 (Netherlands).

bottom of page